224 related articles for article (PubMed ID: 7491782)
1. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus.
Grubman MJ; Zellner M; Bablanian G; Mason PW; Piccone ME
Virology; 1995 Nov; 213(2):581-9. PubMed ID: 7491782
[TBL] [Abstract][Full Text] [Related]
2. Substitution mutations at the putative catalytic triad of the poliovirus 3C protease have differential effects on cleavage at different sites.
Kean KM; Howell MT; Grünert S; Girard M; Jackson RJ
Virology; 1993 May; 194(1):360-4. PubMed ID: 8097606
[TBL] [Abstract][Full Text] [Related]
3. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli.
Bablanian GM; Grubman MJ
Virology; 1993 Nov; 197(1):320-7. PubMed ID: 8212567
[TBL] [Abstract][Full Text] [Related]
5. Effects of P2 cleavage site mutations on poliovirus polyprotein processing.
Cohen L; Kean KM; Girard M; Van der Werf S
Virology; 1996 Oct; 224(1):34-42. PubMed ID: 8862397
[TBL] [Abstract][Full Text] [Related]
6. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
[TBL] [Abstract][Full Text] [Related]
8. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases.
Allaire M; Chernaia MM; Malcolm BA; James MN
Nature; 1994 May; 369(6475):72-6. PubMed ID: 8164744
[TBL] [Abstract][Full Text] [Related]
9. Effect of expression of the aphthovirus protease 3C on viral infection and gene expression.
Martínez-Salas E; Domingo E
Virology; 1995 Sep; 212(1):111-20. PubMed ID: 7676620
[TBL] [Abstract][Full Text] [Related]
10. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical amino acids within the foot-and-mouth disease virus leader protein, a cysteine protease.
Roberts PJ; Belsham GJ
Virology; 1995 Oct; 213(1):140-6. PubMed ID: 7483257
[TBL] [Abstract][Full Text] [Related]
12. Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus.
Piccone ME; Zellner M; Kumosinski TF; Mason PW; Grubman MJ
J Virol; 1995 Aug; 69(8):4950-6. PubMed ID: 7609064
[TBL] [Abstract][Full Text] [Related]
13. Cleavage site mutations in the encephalomyocarditis virus P3 region lethally abrogate the normal processing cascade.
Hall DJ; Palmenberg AC
J Virol; 1996 Sep; 70(9):5954-61. PubMed ID: 8709217
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein.
Nestorowicz A; Chambers TJ; Rice CM
Virology; 1994 Feb; 199(1):114-23. PubMed ID: 8116234
[TBL] [Abstract][Full Text] [Related]
15. Requirement for HC-Pro processing during genome amplification of tobacco etch potyvirus.
Kasschau KD; Carrington JC
Virology; 1995 May; 209(1):268-73. PubMed ID: 7747479
[TBL] [Abstract][Full Text] [Related]
16. Insights into the enzyme-substrate interaction in the norovirus 3C-like protease.
Someya Y; Takeda N
J Biochem; 2009 Oct; 146(4):509-21. PubMed ID: 19556225
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells.
Kristensen T; Normann P; Gullberg M; Fahnøe U; Polacek C; Rasmussen TB; Belsham GJ
J Gen Virol; 2017 Mar; 98(3):385-395. PubMed ID: 27902359
[TBL] [Abstract][Full Text] [Related]
18. Mutational analyses support a model for the HRV2 2A proteinase.
Sommergruber W; Seipelt J; Fessl F; Skern T; Liebig HD; Casari G
Virology; 1997 Aug; 234(2):203-14. PubMed ID: 9268151
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.
Ma W; Wei J; Wei Y; Guo H; Jin Y; Xue Y; Wang Y; Yi Z; Liu L; Huang J; Wang L
Arch Virol; 2014 Jul; 159(7):1715-22. PubMed ID: 24473707
[TBL] [Abstract][Full Text] [Related]
20. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates.
Schultheiss T; Sommergruber W; Kusov Y; Gauss-Müller V
J Virol; 1995 Mar; 69(3):1727-33. PubMed ID: 7853510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
